Episode 42: Alzheimer's Disease: Predictors and Early Intervention

23 MIN 17 SEC , MP3 FORMAT

Download: http://media-download.unimelb.edu.au/media/mp3/upclose/128kbps/upclose_ep042_20080620_128kbps.mp3

Listen: http://upclose.unimelb.edu.au/episode/141?start=1

Transcript: http://upclose.unimelb.edu.au/transcript/140

"But what we are actually looking for is early diagnostic markers. Things that you can actually take a picture of, or do a blood test on, or get some other kind of test that can say, ‘gee, you’re at risk of getting Alzheimer’s disease in ten year’s time because you’ve got this marker in you.’ " - Prof David Ames

David Ames

David Ames is University of Melbourne Foundation Professor of Psychiatry of Old Age at St. George’s Hospital Kew, Director of the National Ageing Research Institute, and University of Melbourne Foundation Professor of Ageing and Health.

His main research interests are new drug treatments for Alzheimer’s disease and the care of the depressed elderly. He is Chief Investigator on the $3 million 3 year Alzheimer study funded by CSIRO (Australian Imaging Biomarkers & Lifestyle Study) 2006-9.

David Ames has published over 100 papers in peer reviewed journals. He edited IPA Bulletin the quarterly newsletter of IPA from 1996-2002, he is a member of the Medical & Scientific Advisory Panel of Alzheimer’s Disease International and has been Editor of the Peer Reviewed Journal International Psychogeriatrics since January 2003.


USEFUL LINKS

Publications

Peer Reviewed Medical Journals

MAURIER K, CUMMINGS J, McKEITH I, AMES D and BURNS A (2006) Has treatment for Alzheimer's disease changed over the last 100 years? Lancet 368: 1619-1621

AMES D, PETERSEN, R, KNOPMAN D, VISSER PJ, BROADTY H, GAUTHIER S (2006) For debate: is mild congitive impairment a clinically useful concept? International Psychogeriatrics 19: 3, 393 - 414

RITCHIE C, CHIU E, HARRIGAN S, MACFARLANE S, MASTWYK M, HALLIDAY G, HUST|IG H, HALL K, HASSETT A, O'CONNOR D, OPIE J, NAGALINGAM V, SNOWDON J AND AMES D (2006) A comparison of the efficacy and safety of olanzapine and Risperdone in the treatment of elderly patients with schizophrenia: an open study of six months duration. International Journal of Geriatric Psychiatry: 21: 171-179

Books

BURNS A, O'BRIEN J, AMES D (Eds) (2005) Dementia with Lewy Bodies. Taylor & Francis, London ISBN 1 84184 395 4

Buy from Melbourne University Bookshop
Buy from Amazon

RITHCIE C, AMES D, MASTERS C, CUMMINGS J (Eds) (2007) Therapeutic Strategies in Dementia. Clinical Publishing, Oxford, ISBN 1 90439258X

Buy from Amazon

AMES D, CHIU E, LINDESAY J (2007) Guide to psychiatry of old age. Cambridge University Press, Cambridge (in press)

Prof David Ames' home page

National Ageing Research Institute

Department of Psychiatry

CREDITS

Host: Jennifer Cook
Producers: Kelvin Param and Eric van Bemmel
Audio Engineer: Craig McArthur
Theme Music performed by Sergio Ercole. Mr Ercole is represented by the Musicians' Agency, Faculty of Music
Voiceover: Paul Richiardi

Series Creators: Eric van Bemmel and Kelvin Param

Melbourne University Up Close is brought to you by the Marketing and Communications Division in association with Asia Institute.
© The University of Melbourne, 2008. All Rights Reserved.
Source URL: http://www.upclose.unimelb.edu.au/episode/141